
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma
Reem M. Hazem, Anhar A. Mohamed, Nagat Ghareb, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173747-173747
Closed Access | Times Cited: 16
Reem M. Hazem, Anhar A. Mohamed, Nagat Ghareb, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173747-173747
Closed Access | Times Cited: 16
Showing 16 citing articles:
Ehrlich Ascites carcinoma mice model for studying liver inflammation and fibrosis
Nirmala G. Sannappa Gowda, Varsha D. Shiragannavar, Samudyata C. Prabhuswamimath, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100029-100029
Open Access | Times Cited: 27
Nirmala G. Sannappa Gowda, Varsha D. Shiragannavar, Samudyata C. Prabhuswamimath, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100029-100029
Open Access | Times Cited: 27
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
Sherihan Salaheldin Abdelhamid Ibrahim, Sarah A. Abd El‐Aal, Ahmed Reda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Sherihan Salaheldin Abdelhamid Ibrahim, Sarah A. Abd El‐Aal, Ahmed Reda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Alternative experimental approaches to reduce animal use in biomedical studies
Seung Yun Lee, Da Young Lee, Ji Hyeop Kang, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 68, pp. 103131-103131
Closed Access | Times Cited: 19
Seung Yun Lee, Da Young Lee, Ji Hyeop Kang, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 68, pp. 103131-103131
Closed Access | Times Cited: 19
The design and synthesis of potent benzimidazole derivatives via scaffold hybridization and evaluating their antiproliferative and proapoptotic activity against breast and lung cancer cell lines
Mohamed Saleh Elgawish, Mohamed S. Nafie, Asmaa S. A. Yassen, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 9, pp. 4239-4256
Closed Access | Times Cited: 14
Mohamed Saleh Elgawish, Mohamed S. Nafie, Asmaa S. A. Yassen, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 9, pp. 4239-4256
Closed Access | Times Cited: 14
New efficient synthesis of polysubstituted benzo[d]pyrido[1′,2':1,2]imidazo[4,5-f][1,3]diazepines and pyrido[2′,1':2,3]imidazo[1,5-c]quinazolin-7-ium salts via Groebke-Blackburn-Bienaymé/Staudinger/aza-Wittig/carbodiimide-mediated annulation sequence
Long Zhao, Mao-Lin Yang, Hao Chen, et al.
Tetrahedron (2024) Vol. 152, pp. 133834-133834
Closed Access | Times Cited: 2
Long Zhao, Mao-Lin Yang, Hao Chen, et al.
Tetrahedron (2024) Vol. 152, pp. 133834-133834
Closed Access | Times Cited: 2
Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest
Katarzyna Malarz, Jacek Mularski, Michał Kuczak, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1790-1790
Open Access | Times Cited: 15
Katarzyna Malarz, Jacek Mularski, Michał Kuczak, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1790-1790
Open Access | Times Cited: 15
Silymarin inhibits the progression of Ehrlich solid tumor via targeting molecular pathways of cell death, proliferation, angiogenesis, and metastasis in female mice
Maggie E. Amer, Maher A. Amer, Azza I. Othman, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4659-4671
Closed Access | Times Cited: 9
Maggie E. Amer, Maher A. Amer, Azza I. Othman, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4659-4671
Closed Access | Times Cited: 9
Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022)
Atukuri Dorababu
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 416-432
Closed Access | Times Cited: 4
Atukuri Dorababu
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 416-432
Closed Access | Times Cited: 4
Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Tashlen Abel, Jagidesa Moodley, Olive P. Khaliq, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13752-13752
Open Access | Times Cited: 6
Tashlen Abel, Jagidesa Moodley, Olive P. Khaliq, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13752-13752
Open Access | Times Cited: 6
Synthesis, structure analysis, DFT calculations and energy frameworks of new coumarin appended oxadiazoles, to regress ascites malignancy by targeting VEGF mediated angiogenesis
Mahima Jyothi, Banumathi, Zabiulla Zabiulla, et al.
Journal of Molecular Structure (2021) Vol. 1252, pp. 132173-132173
Closed Access | Times Cited: 8
Mahima Jyothi, Banumathi, Zabiulla Zabiulla, et al.
Journal of Molecular Structure (2021) Vol. 1252, pp. 132173-132173
Closed Access | Times Cited: 8
Euphorbia factor L2 suppresses the generation of liver metastatic ascites in breast cancer via inhibiting NLRP3 inflammasome activation
Dongjing Jiang, Xun Liu, Rulan Tan, et al.
International Journal of Molecular Medicine (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 2
Dongjing Jiang, Xun Liu, Rulan Tan, et al.
International Journal of Molecular Medicine (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 2
Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer
Norah F. Alqahtani, Mohammad Y. Alfaifi, Ali Shati A, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 39027-39039
Open Access
Norah F. Alqahtani, Mohammad Y. Alfaifi, Ali Shati A, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 39027-39039
Open Access
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS
Helmy Sakr, Islam Otify, Rezk R. Ayyad, et al.
Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 111-129
Open Access | Times Cited: 1
Helmy Sakr, Islam Otify, Rezk R. Ayyad, et al.
Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 111-129
Open Access | Times Cited: 1
Dose-effect and structure-activity relationships of haloquinoline toxicity towards Vibrio fischeri
Min Li, Yayao Wang, Lu Ma, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 7, pp. 10858-10864
Closed Access | Times Cited: 3
Min Li, Yayao Wang, Lu Ma, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 7, pp. 10858-10864
Closed Access | Times Cited: 3
((Z)-(2,4-difluorophenyl)(1-((2-nitrophenyl)sulfonyl)piperidin-4-yl)methanone oxime): Synthesis, Computational Evaluation on Electronic Properties
Vinayakprasanna N. Hegde, Jayashankar Jayaprakash, Chettijana Prajna, et al.
Letters in Applied NanoBioScience (2022) Vol. 12, Iss. 4, pp. 132-132
Open Access
Vinayakprasanna N. Hegde, Jayashankar Jayaprakash, Chettijana Prajna, et al.
Letters in Applied NanoBioScience (2022) Vol. 12, Iss. 4, pp. 132-132
Open Access
INFLUENCE OF GROWTH FACTORS ON SURVIVAL OF PATIENTS WITH OVARIAN CANCER
Oleg I. Kit, E.V. Verenikina, M. V. Mindar, et al.
Современные проблемы науки и образования (Modern Problems of Science and Education) (2021), Iss. №2 2021, pp. 6-6
Open Access
Oleg I. Kit, E.V. Verenikina, M. V. Mindar, et al.
Современные проблемы науки и образования (Modern Problems of Science and Education) (2021), Iss. №2 2021, pp. 6-6
Open Access